# Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/blood-pressure-and-pulse-donor-eligibility-requirements-compliance-policy-guidance-for-industry/615d0678-665d-430f-b65f-b6436cb2069f

> FDA guidance document: Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy:  Guidance for Industry. Issue date: July 17, 2024. Get complete insights and analysis.

---

## Details

- Title: Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2024-07-17
- Last Changed: 2024-07-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0362">FDA-2022-D-0362</a>

## Related Documents

- [Human Gene Therapy for Rare Diseases:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-rare-diseases-guidance-for-industry/1cebc8e2-7d3b-4c5f-a4c4-78d1fc112099)
- [Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-the-development-of-chimeric-antigen-receptor-car-t-cell-products/cdb5020e-7bcf-4cca-a732-0231b04e3869)
- [Human Gene Therapy for Hemophilia:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-hemophilia-guidance-for-industry/bceafce9-c9f0-4137-9ca5-071464212a06)